Open enrollment: benefits brokers face the hardest renewal cycle yet

OneDigital's benefits leader on specialty drug costs, GLP-1 demand, and 2027 strategy
Open enrollment: benefits brokers face the hardest renewal cycle yet
GROUP BENEFITS
By Steve Randall
Nov 19, 2026

The current renewal cycle is shaping up to be a tough one for the US group benefits industry and the brokers who will come out ahead are those treating cost management as a year-round discipline, not an open enrollment fix.

That is the message from Wes Cowen, National Practice Leader for Employee Benefits at OneDigital, who spoke with Insurance Business Benefits US as part of a series of exclusive interviews capturing early takeaways from open enrollment season and what’s ahead for the industry in 2027.

"The last two years have probably been the most challenging that I've seen in my entire career," said Cowen, who has spent 25 years in the industry, including 15 years at two large national insurance carriers before moving into consulting. "We've really spent a good amount of the last 12 months helping [employers] to prepare for this."

Open enrollment as a finish line, not a starting gun

Where many employers still treat the annual window as the moment to solve benefits cost pressure, Cowen stresses it should be the culmination of a year of strategic work.

"Open enrollment isn't just the start of what we're doing – it's really kind of the finish line of a year of work," he said. "The best clients we're working with right now are already planning for 2028 while their 2027 open enrollment season is still open."

The range of solutions available to employers has never been wider, which creates its own complexity. Cowen's team is working through funding strategy conversations that span fully insured, level-funded, self-funded, and emerging structures such as individual coverage health reimbursement arrangements (ICHRAs) – officially rebranded as CHOICE – alongside pharmacy benefit manager (PBM) transparency reviews, narrow pharmacy and provider networks, and site-of-care shifts for high-cost services such as infusion therapy.

"There's definitely not a one-size-fits-all approach," Cowen said. "We really focus on how to personalize [strategy] to an employer, the employer's own population, the risk profile that exists within that population, and also some local market dynamics."

For benefits brokers navigating the same complexity with their own employer clients, IBB's recent coverage of funding strategy shifts in the current environment suggests there is still work to be done to ensure mid-market employers are aware of all the options.

Specialty drugs and the GLP-1 pressure point

If there is a single cost driver reshaping group health plan design right now, it is specialty pharmacy.

Demand for glucagon-like peptide-1 (GLP-1) medications – a class of drugs originally developed for diabetes and now widely prescribed for weight management – is compounding the pressure. Rather than applying blanket coverage or exclusion policies, Cowen is advising clients to build structured frameworks using clinical criteria, quantity limits, and utilization management.

"It doesn't always have to be all or nothing," he said. "Employers can use clinical criteria, quantity limits, utilization management – there are a number of different ways in which we can help employers to address some of the pain points that exist within their population."

A structured approach to GLP-1s has also been highlighted in a recent report from the National Alliance of Healthcare Purchaser Coalitions’ Pulse of the Purchaser Research Institute (PPRI) and the Alliance for Women’s Health and Prevention (AWHP).

Technology and the case for continuous risk analysis

One of the structural shifts Cowen points to with the most enthusiasm is OneDigital's Impact Studio – a platform built to give advisors and their employer clients continuous, real-time population risk analysis rather than a once-a-year claims snapshot.

"Technology has allowed us to almost have a 24/7 way of analyzing data in the background so that we're constantly able to keep our employers and clients informed of what emerging risk might exist," he said. "And how we can help them to attack that as quickly as possible."

The platform is not intended to replace human advisory judgment, Cowen emphasized – it is designed to inform it. That distinction matters for brokers fielding employer questions about the role of artificial intelligence in benefits administration. "While we have technology able to crunch the data, it really still is delivered by a human," he said.

IBB continues to lead the conversation around the use of AI in the benefits industry and its clients, with some notable opinions on how to marry technology and humans for the optimal outcomes.

Heading into 2027: complexity as opportunity

Despite the pressures, Cowen ended on a measured note of optimism. The complexity making employers anxious is also increasing the value of expert benefits consultation.

"The consultation that our teams are providing to our clients, to employers across America right now, is more valuable today than ever," he said. "It's a very complex system. Having the subject matter expertise in a variety of areas that will help our clients to better understand what their options are really positions us well to provide value."

The post-midterm policy environment adds another variable. Cowen expressed hope that bipartisan attention to the healthcare cost crisis – particularly around pharmacy pricing – could translate into meaningful relief for employer plan sponsors in the year ahead.

"I think everyone is very hopeful that our leaders will listen to what has really been such a challenging time for people looking to find answers to the healthcare cost crisis," he said. "And that our leaders will be able to work together and focus on ways in which they can deliver some relief."

Free newsletter

We'll keep you up-to-date with the latest breaking news, cutting edge opinion, and expert analysis affecting both your business and the industry as whole.

Free newsletter

Our daily newsletter is FREE and keeps you up - to - date with the world of Insurance. Please complete the form below and click on subscribe for daily newsletters from IB US.